HEARTFLOW
HeartFlow is the leader in revolutionizing precision heart care, uniquely combining human ingenuity with advanced technology. HeartFlow’s non-invasive HeartFlow FFRCT Analysis leverages artificial intelligence to create a personalized three-dimensional model of the heart. Clinicians can use this model to evaluate the impact a blockage has on blood flow and determine the best treatment for patients. HeartFlow’s technology is reflective of our Silicon Valley roots and incorporates over two decades of scientific evidence with the latest advances in artificial intelligence. The HeartFlow FFRCT Analysis is commercially available in the United States, UK, Canada, Europe and Japan. For more information, visit www.heartflow.com.
HEARTFLOW
Industry:
Artificial Intelligence Biotechnology Health Care Health Diagnostics Medical Software
Founded:
2007-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.heartflow.com
Total Employee:
251+
Status:
Active
Contact:
650-241-1221
Email Addresses:
[email protected]
Total Funding:
577.72 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Domain Not Resolving Amazon IPv6 Google Apps For Business GoDaddy DNS
Similar Organizations
ArrePath
ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
Healx
Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.
Medicago
Medicago is a biotechnology company focused on the research, development, production, and commercialization of vaccines in Canada.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
North Beach Vascular & Aesthetics
North Beach Vascular & Aesthetics is a medical company that provides diagnosis, medical treatment, and cosmetic vascular disorders.
Proscia
Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.
Current Advisors List
Current Employees Featured
Founder
Investors List
Wellington Management
Wellington Management investment in Series E - HeartFlow
Rancilio Cube
Rancilio Cube investment in Series E - HeartFlow
Martis Capital
Martis Capital investment in Series E - HeartFlow
Baillie Gifford
Baillie Gifford investment in Series E - HeartFlow
Panorama Point Partners
Panorama Point Partners investment in Series D - HeartFlow
Lifeforce Capital
Lifeforce Capital investment in Series C - HeartFlow
Capricorn Investment Group
Capricorn Investment Group investment in Series C - HeartFlow
HealthCor Partners
HealthCor Partners investment in Seed Round - HeartFlow
U.S. Venture Partners
U.S. Venture Partners investment in Seed Round - HeartFlow
Emergent Medical Partners
Emergent Medical Partners investment in Seed Round - HeartFlow
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-01 | HeartFlow announces new CEO |
| 2021-08-04 | HeartFlow appoints former Medtronic executive as COO |
Official Site Inspections
http://www.heartflow.com Semrush global rank: 2.66 M Semrush visits lastest month: 6.34 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "HeartFlow"
Heartflow - Crunchbase Company Profile & Funding
Heartflow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.See details»
Heartflow - LinkedIn
Heartflow is the global leader in AI-driven coronary artery disease (CAD) management, transforming how CAD — the world’s leading cause of death — is diagnosed and treated.See details»
HeartFlow: Contact Details, Revenue, Funding, Employees and …
HeartFlow is transforming cardiovascular disease diagnosis with its non-invasive HeartFlow Analysis, a personalized cardiac test that helps physicians make better decisions for patients …See details»
Revolutionizing Precision Heart Care - HeartFlow
HeartFlow brings together human ingenuity and advanced technology to help combat heart disease, the leading cause of death. HeartFlow's non-invasive, personalized cardiac test …See details»
HeartFlow | Bain Capital Life Sciences
HeartFlow is transforming precision coronary care with the only AI-powered non-invasive integrated heart care solution across the CCTA pathway. As the pioneer of FFRCT, which is …See details»
Heartflow, a leader in AI-powered imaging evaluations, …
Jul 18, 2025 Heartflow, known for its AI-based CCTA evaluations, appears to be going public. The news follows years of momentum for the California-based company, including improved Medicare reimbursements for cardiac CT and a …See details»
HeartFlow is a medical technology company that provides various …
HeartFlow focuses on precision heart care, combining human ingenuity with technology. HeartFlow’s non-invasive HeartFlow FFRCT Analysis leverages artificial intelligence to create …See details»
About Us - HeartFlow
Heartflow advances coronary care by empowering clinicians with precision tools and insights to optimize care delivery and achieve the best possible outcomes.See details»
HeartFlow: Transforming the Diagnosis and ... - The …
Founded in 2007, HeartFlow is a medical technology company transforming the way cardiovascular disease is diagnosed and treated. With the company's HeartFlow Analysis, a non-invasive personalized cardiac test, physicians are …See details»
AI leader Heartflow enters new era focused on …
Feb 25, 2025 It is the beginning of a new era for Heartflow. The California-based medtech company, known for its artificial intelligence (AI) -based cardiac CT evaluations, has launched all new branding to highlight its focus on delivering …See details»
Contact Us - heartflow.com
Contact us today for customer support, product support, general inquiries, press inquiries, investor inquiries, and more.See details»
Heartflow Unveils Bold New Vision for Management of Coronary …
Feb 25, 2025 Heartflow is advancing coronary care by transforming coronary artery disease into a screenable, diagnosable, and manageable condition. Heartflow One is the only complete, …See details»
Careers - HeartFlow
Heartflow is a medical technology company transforming the way coronary artery disease (CAD) is diagnosed, treated and managed.See details»
Newsroom - HeartFlow
Feb 25, 2025 Discover the latest news from Heartflow including announcements, clinical data findings, and more.See details»
Home - HeartFlow
HeartFlow and the HeartFlow logo are registered trademarks of HeartFlow, Inc. Additionally, RoadMap is claimed as a trademark of HeartFlow, Inc. © 2025 HeartFlow, Inc.See details»
Heartflow Rebrands, Reaffirms Commitment to Improving CAD …
Feb 26, 2025 Feb. 25, 2025 — Heartflow, Inc., a provider of AI technology for coronary artery disease (CAD) management, recently introduced its new brand identity reflecting its focus on …See details»
What are Mission Vision & Core Values of HeartFlow Company?
Jul 11, 2025 HeartFlow's mission centers on transforming cardiovascular care through AI and personalized solutions. A strong patient-centric approach and commitment to excellence are …See details»
Heartflow Unveils Bold New Vision for Management of
Feb 25, 2025 Heartflow has been adopted by more than 1,400 institutions globally and continues to strengthen its commercial presence to make its cutting-edge solutions more widely available …See details»
Heartflow's Story - YouTube
Feb 25, 2025 Heartflow is the global leader in AI-driven coronary artery disease (CAD) management, transforming how CAD — the world’s leading cause of death — is diagnosed …See details»
Heartflow files for IPO | MedTech Dive
4 days ago Heartflow files for IPO The company reported revenue of $37.2 million in the first quarter, up 39% year over year, but said it has faced challenges in achieving higher rates of …See details»